Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
External review and validation of the Swedish national inpatient register
2011 • 4,308 citations
The Danish Civil Registration System
2011 • 4,056 citations
The Danish National Patient Register
2011 • 3,530 citations
The Danish National Prescription Registry
2011 • 2,130 citations
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research
2009 • 2,072 citations
The Danish Civil Registration System. A cohort of eight million persons.
2006 • 1,582 citations
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
2006 • 1,564 citations
AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland
2012 • 488 citations
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
2009 • 461 citations
Vaccination and autoimmune disease: what is the evidence?
2003 • 351 citations
Efficacy and Safety of Prophylactic Vaccines against Cervical HPV Infection and Diseases among Women: A Systematic Review & Meta-Analysis
2011 • 276 citations
Case Series Analysis of Adverse Reactions to Vaccines: A Comparative Evaluation
1996 • 230 citations
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
2011 • 218 citations
Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis
2013 • 206 citations
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials
2009 • 196 citations
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
2011 • 188 citations
Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011
2011 • 156 citations
Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females
2012 • 112 citations
Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine
2010 • 112 citations
An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010
2012 • 111 citations
Postlicensure epidemiology of childhood vaccination: the Danish experience
2006 • 46 citations
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
2009 • 33 citations
Use of population based background rates of disease to assess vaccine safety in childhood and mass immunisation in Denmark: nationwide population based cohort study
2012 • 28 citations
Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands
2011 • 25 citations
Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events
2009 • 22 citations
Autoimmune diseases after adolescent or adult immunization: What should we expect?
2007 • 19 citations
Evaluation of autoimmune safety signal in observational vaccine safety studies
2012 • 10 citations
Cited By (0)
No citing papers found in database